JamalRahamanMD
Obstetrics & Gynecology • New York, NYGynecologic Oncology
Clinical Professor, Director of Gynecologic Oncology Robotic Training Program, Mt Sinai School of Medicine, New York.
Dr. Rahaman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1136 5th Ave
Ste 1B
New York, NY 10128Phone+1 212-427-1415Fax+1 212-427-1420
Summary
- Dr Rahaman is a Clinical Professor and the current Director of the Robotic Surgical Training Program in Gynecologic Oncology at Mount Sinai. He has been the Fellowship Director of Gynecologic Oncology, the Director of the Gynecologic Oncology Chemotherapy Service, and the Director of Gynecologic Oncology at the Mount Sinai and Elmhurst Hospitals. Since 2017 he has served as a Governor of the American College of Surgeons and on the ACS Surgical Training Workgroup and Education Pillar and in 2021 also appointed as the New York State Commission on Cancer Chair. In 2022 he was elected President of the Association of Attending Staff at Mount Sinai Hospital and serves on the Administrative Executive Committee of the Mount Sinai Medical Board.
He did his Residency in Ob/Gyn and Fellowship training in Gynecologic Oncology at Mount Sinai. He also completed a Fellowship in Cardiac and Vascular surgery with Dr. Denton Cooley at the Texas Heart Institute.
Dr Rahaman's is widely recognized for his special expertise in complicated and challenging pelvic surgery especially laparoscopic and minimally invasive surgery. He is one the first surgeons credentialed to teach and perform da Vinci Robotic surgery for Gynecologic cancers. He is the Principal and co-investigator on several National & International Clinical trials for gynecologic cancers including GOG chemotherapy trials and HPV vaccination trials and translational research to identify predictors of malignant transformation to ovarian cancer. He has authored numerous publications in International journals and written several book chapters in Gynecologic Oncology and has been the recipient of many teaching and peer recognition awards. His clinical practice encompasses the full spectrum of care for gynecologic cancers including surgery, chemotherapy and biologic therapy. He is also a certified colposcopist for Cervical Dysplasia clinical trials and provides complete treatment for pre-invasive disease including laser therapy.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Gynecologic Oncology, 1993 - 1995- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Obstetrics and Gynecology, 1991 - 1993
Lincoln Medical and Mental Health CenterResidency, Obstetrics and Gynecology, 1990 - 1991
Baylor College of MedicineFellowship, Vascular Surgery - Independent, 1988 - 1990
University of the West Indies Faculty of Medical SciencesClass of 1984
Certifications & Licensure
NJ State Medical License 2010 - 2025
NY State Medical License 1998 - 2025
VA State Medical License 1998 - 2024
WV State Medical License 1995 - 2007
OK State Medical License 1992 - 2005
KY State Medical License 1995 - 2003
PA State Medical License 1998 - 2002- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Who's Who in America Marquis, 2008-2020
- Super Doctor SuperDoctors.com, 2008-2020
- Best Doctor Castle Connoly Medical Ltd, 2002-2020
- Join now to see all
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 210 citationsmicroRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transitionAditya Parikh, Christine Lee, Peronne Joseph, Sergio Marchini, Alessia Baccarini
Nature Communications. 2014-01-07 - 126 citationsFallopian tube and primary peritoneal carcinomas associated with BRCA mutations.Douglas A. Levine, Peter A. Argenta, Cindy J. Yee, David S. Marshall, Narciso Olvera
Journal of Clinical Oncology. 2003-11-15 - 73 citationsComparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.Farr Nezhat, Carmel Cohen, Jamal Rahaman, Herbert Gretz, B S Patrick Cole
Cancer. 2002-06-01
Books/Book Chapters
Committees
- President, Executive Committee- Association of Attending Staff, Mt Sinai Hospital 2022 - Present
- Board Member- AAS President, Mount Sinai Hospital Medical Board 2020 - Present
- ACS Governor, ACS Surgical Training Workgroup 2018 - Present
- ACS Governor, ACS Education Pillar 2018 - Present
- Governor, Manhattan Council - American College of Surgeons 2017 - Present
- Member, Clinical Practice Committee - Society of Gynecologic Oncology 2011 - Present
- Member, Robotic Surgery Committee - Mount Sinai Medical Center 2008 - Present
- Gynecologic Oncology Representative, Cancer Committee -Mount Sinai Medical Center 2004 - Present
- Member, Data Safety Monitoring Committee - Mount Sinai Medical Center 2007 - 2010
- Member, Ruttenberg Cancer Center Management Committee - Mount Sinai Medical Center 2003 - 2010
Professional Memberships
- Member
- Member
- Member
- Society of Gynecologic OncologistsMember
- International Gynecologic Cancer SocietyMember
- New York Obstetrical SocietyMember
- Fellow
- Governor
Other Languages
- Spanish
External Links
- linkedinhttp://www.linkedin.com/pub/jamal-rahaman-md/35/28b/2ba
- personal websitehttp://www.mountsinai.org/profiles/jamal-rahaman
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
